Trials / Completed
CompletedNCT01675895
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration
Addition of Lidocaine to Levobupivacaine Reduces Intrathecal Block Duration: Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Diskapi Teaching and Research Hospital · Academic / Other
- Sex
- Male
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The main objective was to test the hypothesis that adding lidocaine to hyperbaric levobupivacaine could change the duration of levobupivacaine spinal block.
Detailed description
A satisfactory spinal anaesthesia requires both a fast onset and proper duration at the same time. Transurethral resection of the prostate (TUR-P) is a surgery of medium duration. The addition of lidocaine to hyperbaric bupivacaine shortens the duration of bupivacaine spinal block and therefore provides more rapid recovery. This property of lidocaine is not verified with other local anesthetics. Levobupivacaine is a S-enantiomer of racemic bupivacaine and is a long acting local anesthetic.The aim of this prospective randomized controlled study was to investigate this effect of lidocaine, with a local anesthetic other than bupivacaine. It was hypothesized that the duration of the intrathecal block could change when performed with hyperbaric levobupivacaine mixed with low dose lidocaine and this technique could be consistent for the duration of TUR-P surgery. Participants will be followed on the day of surgery for primary and secondary outcome measures and 3 days postoperatively for complications (TNS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levobupivacaine lidocaine spinal anesthesia | Spinal anesthesia |
| DRUG | levobupivacaine Spinal anesthesia | spinal anesthesia |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2012-08-30
- Last updated
- 2012-12-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01675895. Inclusion in this directory is not an endorsement.